Cyclandelate in the prophylaxis of migraine: A placebo-controlled study

Cephalalgia

Volumn 21, Issue 1, 2001, Pages 66-70

  Diener, Hans Christoph ^a   Krupp, P ^b   Schmitt, T ^b   Steitz, G ^b   Milde, K ^c   Freytag, S ^d   Schimek, J ^b   Heim, M ^b   Krohn, T ^b   Fritsche, B ^b   Nolte, T ^b   Steinberg, B ^b   Malek, R ^b   Rovenich F ^b   Stolkzi, B ^b   Gross, H D ^b   Olbrich, H ^b   Schwittmann, B ^b   Beikufner H D ^b   Gravenhorst, B H ^b   Huss, F ^b   Jansen, J P ^b   Ost Muller L ^b   Stumpf, G ^b   Hungerland, R ^b   Imhof, E ^b   Krause, L ^b   Langohr, H H ^b   Boest, V ^b   Braunsdorf, L ^b   Gastmeier, K ^b   Kayser, H ^b   Mokesch M ^b   Richer, V ^b   Burgermeister P ^b   Eckhardt, U ^b   Fuchs, J ^b   Grunerbel A ^b   Lopez, E ^b   Schmidt, H J ^b   Halbroth, B ^b   Straube, A ^b   Thumler R ^b   more..

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b 3 M Medica ^*

^c Medical Department   (Germany)

^d KFM Clinical Research Inc   (Germany)

Author keywords

Cyclandelate; Efficacy parameters; Migraine prophylaxis; Placebo

Indexed keywords

CYCLANDELATE; PLACEBO;

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

EID: 0035043756     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2001.00153.x     Document Type: Article

References (15)

1. Propranolol in the management of recurrent migraine: A meta-analytic review
2. Flunarizine vs propranolol: A meta-analysis of clinical trials
3. The pharmacotherapy of focal cortical ischemia in the mouse
4. Dihydropyridiine and -conotoxin-resistant, neomycine-sensitive calcium channels mediate the depolarization induced increase in internal calcium levels in cortical slices from immature rat brain
5. ++-translocation in human platelets
6. Inhibition of human platelet functions by cyclandelate
7. Comparative efficacy of cyclandelate versus flunarizine in the prophylactic treatment of migraine
8. Efficacy and tolerance of cyclandelate versus pizotifen in the prophylaxis of migraine
9. Cyclandelate versus propranolol. Clinical and neurophysiological control of therapeutic efficacy in prophylaxis of migraine. Results of a double blind study
10. Cyclandelate in the prophylaxis of migraine: A randomized, parallel, double-blind study in comparison with placebo and propranolol
11. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
12. The International Headache Society Committee on Clinical Trials in Migraine. Guidelines for controlled trials of drugs in migraine. First edition
13. Clinical efficacy and central mechanisms of cyclandelate in migraine: A double-blind placebo-controlled study
14. Comparative therapeutic efficacy of flunarizine and cyclandelate